Deborah Anne Buonagurio

Title: Deborah Anne Buonagurio: Innovator in Synthetic Gene Technology

Introduction

Deborah Anne Buonagurio is a prominent inventor based in Mamaroneck, NY (US). She has made significant contributions to the field of synthetic gene technology, holding 2 patents that showcase her innovative work. Her research focuses on the construction and expression of synthetic genes, particularly in relation to human retroviruses.

Latest Patents

Buonagurio's latest patents include groundbreaking work on synthetic genes encoding envelope proteins. One of her patents describes a synthetic gene that codes for at least one epitope from the immunodominant conserved region of HTLV-I env. gp 21. This patent also covers hybrid genes that utilize the synthetic gene in conjunction with other epitopes from HTLV-I env. gp 46 and gp 21. The corresponding gene products, recombinant vectors containing the genes, methods for producing the polypeptides, and methods for detecting antibodies to HTLV-I using the polypeptides of the invention are also detailed in her work.

Career Highlights

Throughout her career, Deborah has worked with notable companies such as Hoffmann-La Roche Inc. and Roche Diagnostic Systems, Inc. Her experience in these organizations has allowed her to develop her expertise in synthetic gene technology and contribute to advancements in the field.

Collaborations

One of her notable collaborators is Mathew Longiaru, with whom she has worked on various projects related to her patents and research.

Conclusion

Deborah Anne Buonagurio is a distinguished inventor whose work in synthetic gene technology has the potential to impact medical research and diagnostics significantly. Her contributions continue to pave the way for future innovations in the field.